Fulgent Genetics, Inc. (FLGT)

Fulgent Genetics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	117.64	55.14	97.47	79.51	164.89	87.43
Short-Term Investments	258.16	202.96	326.68	446.73	285.61	211.94
Cash & Short-Term Investments	375.8	258.11	424.15	526.24	450.5	299.37
Cash Growth	76.38%	-39.15%	-19.40%	16.81%	50.48%	958.99%
Accounts Receivable	71.19	69.02	51.13	52.75	139.15	185.24
Other Receivables	-	8.01	6.31	22.36	4.15	18.83
Receivables	71.19	77.03	57.45	75.11	143.3	204.06
Prepaid Expenses	-	6.63	7.74	6.81	4.24	3.68
Other Current Assets	60.38	11.81	18.5	19.71	13.92	16.51
Total Current Assets	507.37	353.57	507.85	627.87	611.96	523.62
Property, Plant & Equipment	111.87	111.72	95.62	98.92	71.16	41.03
Long-Term Investments	411.78	595.28	444.01	339.03	507.01	132.5
Goodwill	25.08	22.06	22.06	143.03	50.9	-
Other Intangible Assets	135.26	134.98	143.05	150.64	35.91	-
Long-Term Deferred Tax Assets	-	-	-	3.5	0.76	1.63
Other Long-Term Assets	23.21	2.37	22.75	23.05	1.02	1.69
Total Assets	1,215	1,220	1,235	1,386	1,279	700.46
Accounts Payable	18.09	18.36	15.36	23.09	20.49	26.39
Accrued Expenses	23.01	22.44	26.24	17.91	15.52	8.54
Short-Term Debt	-	-	-	15	21.28	15.02
Current Portion of Long-Term Debt	0.48	0.41	1.18	5.64	-	-
Current Portion of Leases	-	1.84	4.5	7.08	2.17	-
Current Income Taxes Payable	-	-	-	-	0.79	53.32
Current Unearned Revenue	2.31	2.23	2.87	3.2	14.57	26.58
Other Current Liabilities	28.54	27.61	22.86	16.2	30.49	0.27
Total Current Liabilities	72.43	72.9	73.02	88.11	105.31	130.12
Long-Term Debt	-	2.49	2.96	-	-	-
Long-Term Leases	-	4.48	7.91	10.61	6.74	0.57
Long-Term Deferred Tax Liabilities	7.04	6.37	7.96	-	-	-
Other Long-Term Liabilities	14.34	4.56	10.19	17.46	0.79	0.39
Total Liabilities	93.81	90.81	102.04	116.18	112.84	131.07
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	565.69	543.13	501.72	486.59	501.91	418.07
Retained Earnings	553.37	590.47	633.18	801	657.6	150.88
Comprehensive Income & Other	6.82	-0.37	1.21	-20.9	-0.76	0.44
Total Common Equity	1,126	1,133	1,136	1,267	1,159	569.39
Minority Interest	-5.13	-4.07	-2.82	3.19	7.13	-
Shareholders' Equity	1,121	1,129	1,133	1,270	1,166	569.39
Total Liabilities & Equity	1,215	1,220	1,235	1,386	1,279	700.46
Total Debt	0.48	9.23	16.56	38.33	30.2	15.59
Net Cash (Debt)	787.11	819.23	831.17	814.56	905.35	416.28
Net Cash Growth	-2.27%	-1.44%	2.04%	-10.03%	117.48%	516.35%
Net Cash Per Share	25.64	27.10	27.91	26.31	29.23	17.30
Filing Date Shares Outstanding	30.91	30.83	29.78	29.52	30.25	28.87
Total Common Shares Outstanding	30.85	30.84	29.65	29.44	30.16	28.18
Working Capital	434.95	280.67	434.83	539.77	506.65	393.5
Book Value Per Share	36.49	36.74	38.31	43.03	38.42	20.21
Tangible Book Value	965.55	976.2	970.99	973.02	1,072	569.39
Tangible Book Value Per Share	31.29	31.65	32.75	33.05	35.54	20.21
Land	-	17.35	8.8	7.5	7.5	7.5
Buildings	-	49.61	17.53	12.6	10.67	7.44
Machinery	-	76.07	73.65	71.97	51.22	31.6
Leasehold Improvements	-	3.32	11.22	11.8	4	1.58

Updated Nov 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q